Lixte Biotechnology (LIXT) Short Interest Ratio & Short Volume → The Long-Awaited End of America Update (From Stansberry Research) (Ad) Free LIXT Stock Alerts $2.88 0.00 (0.00%) (As of 05/2/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Lixte Biotechnology Short Interest DataCurrent Short Volume82,700 sharesPrevious Short Volume16,700 sharesChange Vs. Previous Month+395.21%Dollar Volume Sold Short$272,910.00Short Interest Ratio / Days to Cover0.2Last Record DateApril 15, 2024Outstanding Shares2,250,000 sharesFloat Size1,800,000 sharesShort Percent of Float4.59%Today's Trading Volume8,687 sharesAverage Trading Volume420,673 sharesToday's Volume Vs. Average2% Short Selling Lixte Biotechnology ? Sign up to receive the latest short interest report for Lixte Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLIXT Short Interest Over TimeLIXT Days to Cover Over TimeLIXT Percentage of Float Shorted Over Time Ad Paradigm PressBiden out June 13; Kamala won’t replace him?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. Lixte Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202482,700 shares $272,910.00 +395.2%4.6%0.2 $3.30 3/31/202416,700 shares $56,446.00 -14.8%1.0%0 $3.38 3/15/202419,600 shares $45,276.00 -62.3%1.1%0.5 $2.31 2/29/202452,000 shares $135,200.00 +258.6%3.0%1.4 $2.60 2/15/202414,500 shares $39,440.00 +42.2%0.8%0.3 $2.72 1/31/202410,200 shares $21,063.00 +117.0%0.6%0.4 $2.07 Get the Latest News and Ratings for LIXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lixte Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 1/15/20244,700 shares $9,118.00 -63.0%0.3%0.1 $1.94 12/31/202312,700 shares $29,845.00 -32.5%0.7%0.3 $2.35 12/15/202318,800 shares $39,668.00 -26.0%1.1%0.4 $2.11 11/30/202325,400 shares $59,182.00 -60.1%1.5%0.5 $2.33 11/15/202363,700 shares $184,730.00 +295.7%3.7%1.2 $2.90 10/31/202316,100 shares $38,720.50 -1.8%0.9%0.4 $2.41 10/15/202316,400 shares $39,360.00 -44.6%1.0%0.3 $2.40 9/30/202329,600 shares $72,520.00 +261.0%2.1%0.2 $2.45 9/15/20238,200 shares $17,384.00 +13.9%0.6%0.1 $2.12 8/31/20237,200 shares $18,036.00 -44.2%0.3%0.1 $2.51 8/15/202312,900 shares $32,250.00 -84.3%0.6%0.1 $2.50 7/31/202382,200 shares $289,344.00 +774.5%4.7%0.6 $3.52 7/15/20239,400 shares $51,042.00 +8.1%1.0%0.1 $5.43 6/30/20238,700 shares $50,721.00 -28.7%0.5%0.4 $5.83 6/15/202312,200 shares $57,950.00 +306.7%1.5%0.7 $4.75 5/31/20233,000 shares $20,784.00 -86.2%0.4%0.3 $6.93 5/15/202321,800 shares $14,483.92 +162.7%0.3%0.2 $0.66 4/30/20238,300 shares $4,656.30 -80.0%0.1%0 $0.56 4/15/202341,500 shares $26,153.30 -45.8%0.5%0 $0.63 3/31/202376,500 shares $63,288.45 -39.1%1.0%0.1 $0.83 3/15/2023125,700 shares $85,853.10 +31.5%1.7%0.1 $0.68 2/28/202395,600 shares $86,757.00 -38.7%1.3%0.1 $0.91 2/15/2023156,000 shares $180,960.00 +459.1%2.1%0.1 $1.16 1/31/202327,900 shares $22,041.00 -62.6%0.4%0 $0.79 1/15/202374,500 shares $42,465.00 +89.1%1.0%2 $0.57 12/30/202239,400 shares $20,054.60 -7.9%0.5%1.2 $0.51 12/15/202242,800 shares $23,171.92 -15.9%0.6%1.7 $0.54 11/30/202250,900 shares $38,938.50 +53.3%0.7%1.8 $0.77 11/15/202233,200 shares $18,283.24 +26.7%0.5%1.1 $0.55 10/31/202226,200 shares $13,105.24 +5.2%0.4%0.5 $0.50 10/15/202224,900 shares $12,980.37 -58.5%0.4%0.2 $0.52 9/30/202260,000 shares $33,612.00 +64.4%0.9%0.5 $0.56 9/15/202236,500 shares $25,761.70 -43.4%0.5%0.3 $0.71 8/31/202264,500 shares $50,310.00 -30.0%0.9%0.5 $0.78The biggest energy story ever? (Ad)Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie…For the full story, click here. LIXT Short Interest - Frequently Asked Questions What is Lixte Biotechnology's current short interest? Short interest is the volume of Lixte Biotechnology shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 82,700 shares of LIXT short. 4.59% of Lixte Biotechnology's shares are currently sold short. Learn More on Lixte Biotechnology's current short interest. What is a good short interest percentage for Lixte Biotechnology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.59% of Lixte Biotechnology's floating shares are currently sold short. Is Lixte Biotechnology's short interest increasing or decreasing? Lixte Biotechnology saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 82,700 shares, an increase of 395.2% from the previous total of 16,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lixte Biotechnology's float size? Lixte Biotechnology currently has issued a total of 2,250,000 shares. Some of Lixte Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lixte Biotechnology currently has a public float of 1,800,000 shares. How does Lixte Biotechnology's short interest compare to its competitors? 4.59% of Lixte Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Lixte Biotechnology: Xenetic Biosciences Inc (0.22%), Ainos, Inc. (2.84%), Processa Pharmaceuticals, Inc. (8.28%), Kineta, Inc. (1.23%), Shuttle Pharmaceuticals Holdings, Inc. (0.77%), Enveric Biosciences, Inc. (1.40%), TFF Pharmaceuticals, Inc. (2.77%), Adial Pharmaceuticals, Inc. (26.72%), Protagenic Therapeutics, Inc. (0.28%), Pulmatrix, Inc. (0.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Lixte Biotechnology stock? Short selling LIXT is an investing strategy that aims to generate trading profit from Lixte Biotechnology as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lixte Biotechnology? A short squeeze for Lixte Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LIXT, which in turn drives the price of the stock up even further. How often is Lixte Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LIXT, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: XBIO Short Interest Data AIMD Short Interest Data PCSA Short Interest Data KA Short Interest Data SHPH Short Interest Data ENVB Short Interest Data TFFP Short Interest Data ADIL Short Interest Data PTIX Short Interest Data PULM Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LIXT) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsTruth about Trump you’ve never heardPorter & CompanyHe Is Giving Away BitcoinCrypto Swap ProfitsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithAI “wealth window” is closing June 25thParadigm Press4 Cryptos BETTER than BitcoinTrue Market Insiders